Applied Microbiology and Biotechnology, Vol.101, No.23-24, 8431-8441, 2017
The R117A variant of the Escherichia coli transacylase FabD synthesizes novel acyl-(acyl carrier proteins)
The commercial impact of fermentation systems producing novel and biorenewable chemicals will flourish with the expansion of enzymes engineered to synthesize new molecules. Though a small degree of natural variability exists in fatty acid biosynthesis, the molecular space accessible through enzyme engineering is fundamentally limitless. Prokaryotic fatty acid biosynthesis enzymes build carbon chains on a functionalized acyl carrier protein (ACP) that provides solubility, stability, and a scaffold for interactions with the synthetic enzymes. Here, we identify the malonyl-coenzyme A (CoA)/holo-ACP transacylase (FabD) from Escherichia coli as a platform enzyme for engineering to diversify microbial fatty acid biosynthesis. The FabD R117A variant produced novel ACP-based primer and extender units for fatty acid biosynthesis. Unlike the wild-type enzyme that is highly specific for malonyl-CoA to produce malonyl-ACP, the R117A variant synthesized acetyl-ACP, succinyl-ACP, isobutyryl-ACP, 2-butenoyl-ACP, and beta-hydroxybutyryl-ACP among others from holo-ACP and the corresponding acyl-CoAs with specific activities from 3.7 to 120 nmol min(-1) mg(-1). FabD R117A maintained K (M) values for holo-ACP (similar to 40 mu M) and displayed small changes in K (M) for acetoacetyl-CoA (110 +/- 30 mu M) and acetyl-CoA (200 +/- 70 mu M) when compared to malonyl-CoA (80 +/- 30 mu M). FabD R117A represents a novel catalyst that synthesizes a broad range of acyl-acyl-ACPs.
Keywords:Protein engineering;Metabolic design;MCAT;Malonyl-coenzyme A (CoA)/holo-ACP transacylase;ACP